Monotropein

1 paper5 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab

Animals1

Outcomes

Triglyceride

downin rats1

1 study

Monotropein decreases triglyceride in rats.
“MON also reduced age-associated increases in total cholesterol and triglyceride levels”
Animals40 mg/kg/day4 weeksmales
Monotropein improves late-onset hypogonadism in TM3 Leydig cells and aged rats
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie3 Nov 2025

Latest

1 in 12 months

Biomedicine & Pharmacotherapy5 Nov

Monotropein improves late-onset hypogonadism in TM3 Leydig cells and aged rats

Experiments in ratsInterventions

Paper

Monotropein

Outcomes

Latest

Monotropein improves late-onset hypogonadism in TM3 Leydig cells and aged rats

Related